Rebekah Bernard, MD, on the importance of physician-led care | COVID-19 Update
Rebekah Bernard, MD, on the importance of physician-led care | COVID-19 Update
A special episode with Rebekah Bernard, MD, co-author of the book Patients at Risk: The Rise of the Nurse Practitioner and Physician Assistant in Healthcare about scope creep and how it can affect patient care. American Medical Association CXO Todd Unger hosts.To learn more about the AMA’s work to fight scope creep as a critical part of our Recovery Plan for America’s Physicians, visit: ama-assn.org/recovery
0:00 AMA COVID-19 Update for August 23, 2022
1:16 Why write a book about scope creep?
3:05 Share Alexus Ochoa-Dockins' story
4:40 How pervasive is scope creep?
5:46 Findings from 2019 study: “Potential Crisis in Nurse Practitioner Preparation in the United States"
8:01 What is the AMA "Truth in Advertising" campaign?
10:33 Expand on solutions to fight scope creep
12:09 Physician-led care teams are key
Stay up to date on the latest information about the pandemic: https://ama-assn.org/covid-19-resources.
Visit the COVID-19 Daily Video Updates page for more videos in this series: https://ama-assn.org/covid-19-videos.
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.